The CHAMP Study

The CHAMP Study is closed to new enrollments. Check out the CHAPERONE study if you're interested in participating in this type of research!

The Childhood Atropine for Myopia Progression (CHAMP) study is a 3-arm randomized, multicenter, double-masked, placebo-controlled study that's ongoing at more than 20 sites across the country and in Europe! Stage 1 of the trial is evaluating the safety and efficacy of using low-concentration atropine or placebo to slow myopia progression. Stage 2 is a randomized cross-over phase of 1 year in duration, during which subjects will be re-randomized to receive one of the three study medications.

Treatment arms are:

• low dose atropine 0.01%

• low dose atropine 0.02%

• vehicle (placebo)